Insider · CIK 0001991325
Andrew Regan
ceoofficerdirectorowner
Files at CDT (CONDUIT PHARMACEUTICALS INC.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 28, 2026 | CDT CONDUIT PHARMACEUTICALS INC. | JOther Common Stockindirect: By Corvus Capital Ltd. | +5,436,830 | - | - | 5,693,223 | 40 d ago |
| Aug 28, 2026 | CDT CONDUIT PHARMACEUTICALS INC. | SOpen-market sale Common Stockindirect: By Corvus Capital Ltd. | -290 | - | - | 5,692,933 | 40 d ago |
| Jul 30, 2026 | CDT CONDUIT PHARMACEUTICALS INC. | JOther Pre-Funded Warrantsderivativeindirect: By Corvus Capital Ltd. | +5,436,830 | $0.00 | $544 | 5,436,830 | 40 d ago |
| Aug 28, 2026 | CDT CONDUIT PHARMACEUTICALS INC. | XIn-the-money exercise Pre-Funded Warrantsderivativeindirect: By Corvus Capital Ltd. | -5,436,830 | $0.00 | $544 | 0 | 40 d ago |
| Jun 3, 2025 | CDT CONDUIT PHARMACEUTICALS INC. | AGrant or award Common Stockindirect: See Footnote | +154,799 | $3.23 | $500k | 154,799 | Jun 13, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.